EGb761 blocks MPP+-induced lipid peroxidation in mouse corpus striatum

Neurochemical Research

Volumn 26, Issue 11, 2001, Pages 1245-1251

  Rojas, Patricia ^a   Garduño, Belén ^a   Rojas, Carolina ^b   Vigueras, Rosa María ^c   Rojas Castañeda, Julio ^c   Ríos, Camilo ^a   Serrano Garcia, Norma ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

EGb761; Lipid peroxidation; MPP+; Neuroprotection; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE; GINKGO BILOBA EXTRACT; NEUROPROTECTIVE AGENT; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIET SUPPLEMENTATION; DOPAMINE RELEASE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CORPUS STRIATUM; GINKGO BILOBA; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; NEUROTOXINS; PLANT EXTRACTS;

ANIMALIA; GINKGO BILOBA;

EID: 0035716773     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013971524150     Document Type: Article

References (49)

1. Clues to the mechanism underlying dopamine cell death in Parkinson's disease
2. Recent progress in the neurochemistry of Parkinson's disease
3. Oxidative processes and antioxidative defense mechanisms in the aging brain
4. Oxygen radicals as key mediators in neurological disease: Fact or fiction?
5. Dynamics of lipid peroxidation and its inhibition by antioxidants
6. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in increased iron and melanin induced neurodegeneration?
7. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia
8. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
9. Levodopa-based therapy
10. Clinical pathophysiology of basal ganglia diseases
11. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease
12. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
13. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridinium, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
14. Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse
15. Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
16. MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes
17. The oxidative inactivation of mitochondrial eletron transport chain components and ATPase
18. Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity
19. Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
20. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
21. + administration to mice
22. Depletion of copper and manganese in brain after MPTP treatment of mice
23. Short-term manganese pretreatment partially protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
24. + neurotoxicity in mice
25. Antioxidant action of Ginkgo biloba extract EGb761
26. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb761
27. Ginkgo biloba extract (EGb761): Inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7
28. Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP
29. Motor function in young and aged hemiplegic rats: Effects of a Ginkgo biloba extract
30. + in mice: Effects of simultaneously administered nomifensine, deprenyl and 1-t-butyl-4,4-diphenylpiperidine
31. 3H-DOPA in various regions of the brain
32. 2+ injection
33. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb761
34. Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves
35. Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals
36. 2+ induced decrease in synaptosomal membrane fluidity
37. A Ginkgo biloba extract (EGb761) prevents mitochondrial aging by protecting against oxidative strees
38. Ginkgo biloba extract protects brain neurons against oxidative strees induced by hydrogen peroxide
39. Effects of an extract of Ginkgo biloba on bromethalin-induced cerebral lipid peroxidation and edema in rats
40. Flavonoids as antioxidants: Determination of radical-scavenging efficiencies
41. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation
42. Flavonoids, a class of natural high pharmacological potency
43. Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo and some flavonoids
44. Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes
45. Peroxidation induced changes in synaptosomal transport of dopamine and gama-aminobutyric acid
46. Prevention by Ginkgo biloba extract (EGb761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation
47. Absorption, distribution et élimination de léxtrait marqué de Ginkgo biloba chez le rat
48. Involvement of monoamine oxidase inhibition in neuroprotective and restorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C-57 mice